D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.27% |
| 2 | Healthcare | 11.28% |
| 3 | Consumer Discretionary | 8.99% |
| 4 | Communication Services | 8.03% |
| 5 | Industrials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
PUT
Travelers Companies
TRV
$80.8B
| $746K | ﹤0.01% |
5,500
| – | – |
|
|
WBK
2702
DELISTED
Westpac Banking Corporation
WBK
| $746K | ﹤0.01% |
30,606
-5,588
| -15% | -$138K |
|
2703
CALL
CF Industries
CF
$19.2B
| $740K | ﹤0.01% |
17,400
-1,300
| -7% | -$49.1K |
|
2704
CALL
Medifast
MED
$108M
| $740K | ﹤0.01% |
+10,600
| New | +$703K |
|
2705
PUT
VF Corp
VFC
$6.68B
| $740K | ﹤0.01% |
10,620
| – | – |
|
2706
Acadia Healthcare
ACHC
$3.17B
| $738K | ﹤0.01% |
+22,618
| New | +$784K |
|
2707
Standex International
SXI
$3.68B
| $733K | ﹤0.01% |
+7,197
| New | +$742K |
|
|
PRTY
2708
DELISTED
Party City Holdco Inc.
PRTY
| $733K | ﹤0.01% |
52,574
-46,613
| -47% | -$574K |
|
|
CADE
2709
DELISTED
Cadence Bank
CADE
| $730K | ﹤0.01% |
23,207
+13,627
| +142% | +$438K |
|
2710
Xerox
XRX
$337M
| $729K | ﹤0.01% |
25,015
-124,401
| -83% | -$3.78M |
|
2711
PUT
Monarch Casino & Resort
MCRI
$2.14B
| $726K | ﹤0.01% |
+16,200
| New | +$718K |
|
2712
PTC
PTC
$13.7B
| $725K | ﹤0.01% |
11,932
-534,415
| -98% | -$33.2M |
|
|
TNAV
2713
DELISTED
Telenav Inc.
TNAV
| $725K | ﹤0.01% |
131,891
+12,897
| +11% | +$72K |
|
2714
Center Bancorp
CNOB
$1.63B
| $724K | ﹤0.01% |
28,103
-1,518
| -5% | -$39.9K |
|
2715
TG Therapeutics
TGTX
$8.58B
| $724K | ﹤0.01% |
88,271
-51,085
| -37% | -$446K |
|
|
SBCP
2716
DELISTED
Sunshine Bancorp, Inc
SBCP
| $723K | ﹤0.01% |
31,507
+8,361
| +36% | +$196K |
|
|
MOBL
2717
DELISTED
MobileIron, Inc.
MOBL
| $723K | ﹤0.01% |
185,399
-157,308
| -46% | -$608K |
|
2718
FB Financial Corp
FBK
$2.95B
| $721K | ﹤0.01% |
17,179
+539
| +3% | +$21.9K |
|
|
JBTM
2719
PUT
JBT Marel
JBTM
$7.14B
| $720K | ﹤0.01% |
+6,500
| New | +$710K |
|
|
GBT
2720
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $720K | ﹤0.01% |
+18,297
| New | +$683K |
|
2721
PUT
Blackrock
BLK
$164B
| $719K | ﹤0.01% |
+1,400
| New | +$681K |
|
|
WUBA
2722
CALL
DELISTED
58.com Inc
WUBA
| $716K | ﹤0.01% |
+10,000
| New | +$693K |
|
|
SFE
2723
DELISTED
Safeguard Scientifics, Inc.
SFE
| $712K | ﹤0.01% |
63,528
+6,441
| +11% | +$82.5K |
|
|
IXYS
2724
DELISTED
IXYS Corp
IXYS
| $710K | ﹤0.01% |
29,656
+1,067
| +4% | +$25.7K |
|
2725
Enova International
ENVA
$5.91B
| $709K | ﹤0.01% |
46,609
+10,182
| +28% | +$149K |
|
Similar funds
D.E. Shaw & Co's Q4 2017 Portfolio in Review
As of Q4 2017, D.E. Shaw & Co held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- D.E. Shaw & Co's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- D.E. Shaw & Co added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- D.E. Shaw & Co's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- D.E. Shaw & Co fully exited Tesla in Q4 2017, selling an estimated $230M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- D.E. Shaw & Co opened 507 new positions and closed 394 in Q4 2017.
- D.E. Shaw & Co's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.